文献速递间质性肺疾病肺结节与肺癌

间质性肺异常与癌症诊断及死亡率的关联

The associations of interstitial lung abnormalities with cancer diagnoses and mortality.
PubMed 文献 · Eur Respir J · 2020-12-17

本研究基于AGES-Reykjavik队列5764名冰岛老年人,评估间质性肺异常与肺癌及其他癌症诊断和死亡率的关联。结果显示间质性肺异常与肺癌诊断风险(HR 2.77)和肺癌死亡风险(HR 2.89)升高相关,但与排除肺癌后的其他癌症无关。提示肺纤维化早期阶段即与肺部肿瘤性疾病相关,间质性肺异常或可作为肺癌筛查的风险因素。

要点

  • 间质性肺异常者肺癌诊断累积发生率更高(p<0.001)。
  • 间质性肺异常者肺癌死亡累积发生率更高(p<0.001)。
  • 调整后间质性肺异常与肺癌诊断(HR 2.77)和死亡(HR 2.89)风险升高相关。

核心结论

  • 间质性肺异常者肺癌诊断和肺癌死亡风险升高,但其他癌症风险未升高。
  • 肺纤维化早期阶段即与肺部肿瘤性疾病存在关联。
  • 间质性肺异常可考虑作为肺癌筛查的风险因素。

研究设计与样本

  • 研究使用AGES-Reykjavik队列数据,纳入5764名冰岛老年人。
  • 结局数据从电子病历中获取。
  • 采用Gray检验、Cox比例风险模型和比例子分布风险模型分析关联。

主要发现

  • 间质性肺异常者肺癌诊断累积发生率更高(p<0.001)。
  • 间质性肺异常者肺癌死亡累积发生率更高(p<0.001)。
  • 调整Cox模型中,间质性肺异常与肺癌诊断风险升高相关(HR 2.77)。
  • 调整Cox模型中,间质性肺异常与肺癌死亡风险升高相关(HR 2.89)。
  • 间质性肺异常与所有癌症的关联在包含肺癌的模型中出现,在排除肺癌的模型中未出现。

关键数值与推荐

  • 肺癌诊断累积发生率比较p<0.001。
  • 肺癌死亡累积发生率比较p<0.001。
  • 肺癌诊断风险比HR 2.77(调整Cox模型)。
  • 肺癌死亡风险比HR 2.89(调整Cox模型)。

临床怎么用

  • 对间质性肺异常患者应关注肺癌风险,考虑纳入肺癌筛查评估。
  • 间质性肺异常可能提示肺纤维化早期即需警惕肺部肿瘤性疾病。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

An increased incidence of lung cancer is well known among patients with idiopathic pulmonary fibrosis. It is not known whether interstitial lung abnormalities, i.e. early fibrotic changes of the lung, are a risk factor for lung cancer in the general population.The study's objective was to assess whether interstitial lung abnormalities were associated with diagnoses of, and mortality from, lung cancer and other cancers. Data from the AGES-Reykjavik study, a cohort of 5764 older Icelandic adults, were used. Outcome data were ascertained from electronic medical records. Gray's tests, Cox proportional hazards models and proportional subdistribution hazards models were used to analyse associations of interstitial lung abnormalities with lung cancer diagnoses and lung cancer mortality as well as diagnoses and mortality from all cancers.There was a greater cumulative incidence of lung cancer diagnoses (p<0.001) and lung cancer mortality (p<0.001) in participants with interstitial lung abnormalities than in others. Interstitial lung abnormalities were associated with an increased hazard of lung cancer diagnosis (hazard ratio 2.77) and lung cancer mortality (hazard ratio 2.89) in adjusted Cox models. Associations of interstitial lung abnormalities with all cancers were found in models including lung cancers but not in models excluding lung cancers.People with interstitial lung abnormalities are at increased risk of lung cancer and lung cancer mortality, but not of other cancers. This implies that an association between fibrotic and neoplastic diseases of the lung exists from the early stages of lung fibrosis and suggests that interstitial lung abnormalities could be considered as a risk factor in lung cancer screening efforts.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Axelsson GT, Putman RK, Aspelund T, et al. The associations of interstitial lung abnormalities with cancer diagnoses and mortality. Eur Respir J. 2020. PMID: 32646918. doi:10.1183/13993003.02154-2019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。